Andrew J. Last Email & Phone Number

Danville, Ca, Us

Houston, Tx, Us

Member of Board for OncoCyte, a public company focused on development of advanced molecular diagnostics in the oncology field.

Hercules, Ca, Us

Executive leadership of Bio-Rad global business operations: Responsible for all key operations for the company - Commercial Channel, Business Groups (incl. R&D), Business Development, Supply Chain, RA/QA, IT, etc. Over 5 + years led significant transformation broadly across the company, while also navigating the COVID pandemic, resulting in a material improvement in performance:

Emeryville, Ca, Us

Lead global commercial growth strategy and its execution for Berkeley Lights' innovative and disruptive new single cell platform. Providing leadership covering, sales, business development, marketing and product management, service, support and operations.Building a world class commercial organization to drive rapid growth of Berkeley Lights breakthrough platform that is significantly reducing the timelines, costs and outputs across all cell focused workflows in life science, therapeutic development and the future of cell therapy.

Germantown, Maryland, Us

Intrexon and our collaborators are building solutions to challenging issues across fields as diverse as medicine, fuel, agriculture, nutrition, personal care, chemicals, and manufacturing, forging a sustainable path forward for current and future generations. We call our approach Better DNA® and invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook and LinkedIn.

Santa Clara, California, Us

Member of the corporate executive leadership team responsible for a $360 mill leader in genomic (RNA& DNA), cell and protein analysis applications across clinical diagnostics, basic research, industry and applied market segments. Company technologies encompass world leading microarray platforms for gene expression, genotyping, and other genomic applications (ie.copy number variation), as well as a world leading immunology and cell based assay portfolio (eBioscience) for flow cytometry and bead based assays (Luminex). Primary focus has been on defining a turnaround strategy and implementing its execution through restructuring, acquisition, and development of new growth drivers. Directly responsible for leading 5 business units containing strategic marketing, product management, R&D, clinical operations, regulatory affairs, QA/QC, and overall manufacturing operations for the company (~660 HC). Previously as CCO directly managed the global sales channel, field marketing, service and support as well as Strategic Marketing and product teams.

Santa Clara, California, Us

Global leadership of Commercial organization (sales, service & support) and Strategic Marketing/Product Management.

Franklin Lakes, New Jersey, Us

Vice President, Global & Strategic Marketing (BioSciences) & General Manager (Pharmingen)Member of executive management team responsible for overall business & portfolio strategy and execution globally for $950 mill + industry leading clinical diagnostic applications, flow cytometery instrument platforms and research reagents. General management responsibility for San Diego based Pharmingen business and all functional groups at the facilities (exceeds 400 HC). Overall responsibilities included driving development & delivery of annual and long term plans covering HIV, leukemia & lymphoma, transplant & transfusion diagnostics and broad research reagent & instrument portfolio. Accountable for defining & prioritizing new product development activities, strategic partnerships and direct ‘life cycle’ management of product portfolio, as well as domestic “go to market” activities and serving as General Manager for Canadian business for the segment

Waltham, Ma, Us

Vice President & General Manager, Member of executive management team responsible for management & direction of Business Unit P&L, strategy and its execution for over $550 mill. Responsibilities covering business development, new product development and management of a broad portfolio of market leading instrument & reagent product lines including “Real Time” PCR (TaqMan), core PCR, Genomic Assays, Micro Arrays, Sample prep, DNA synthesis, & custom oligo’s.• Delivered significant year on year growth in strategically critical product lines. • Launched multiple new product offerings contributing significant new revenue growth. Defined development plans for rapid introduction of new applications. • Upgraded product management capability & delivered 3 year business unit growth plans including all R&D priorities. Built a new senior leadership team & established a comprehensive strategic planning process & delivered prioritized BU goals for the next 3 years.

Wilmington, Delaware, Us

Management & direction of marketing & communications department to deliver annual and long term strategy and business plans for worlds leading genomics information business. Defined and executed global growth plans for product, services and licensing portfolio accounting for $220 mill in annual sales. Management & execution of strategic collaborations and introduction of multiple new product offerings.• Revived stagnating Database sales & drove aggressive global growth in Pharmaceutical & Biotech segments. • Built “high tech” marketing team & delivered corporate strategy for Incyte Genomics. • Directed management & execution of multiple strategic collaborations, IP licensing strategy and the introduction of new product offerings in multiple area’s:

St. Louis, Missouri, Us

Director, Worldwide Brand and Category Management 1996 -1999, Consumer, Food and Nutrition Sector. Packaged goods - Lawn and Garden. Managed development of short and long term strategy, P&L and growth plans for consumer lawn and garden business worldwide ($500 million in sales). Focused on Roundup, Monsanto’s premiere brand franchise and leading consumer weed killer worldwide with $300 million sales. Provided direction on all elements of the marketing mix at country and global level.

Phd, Agrochemicals

Msc, Bio-Aeronautics

Bsc, Biological Sciences